Related Experiment Video
Updated: Oct 2, 2025

05:04
Author Spotlight: A Live Cell Imaging Technique to Study Calcium Signaling and Acrosome Exocytosis in Mouse Sperm
Published on: October 13, 2023
1.2K
A randomized controlled study to compare first stick success with Instaflash technology: The FIRSST study
Arun Mavaji Seetharam1, Umashankar Raju1, K Suresh1
1Department of Hospital Administration, M S Ramaiah Medical College and Hospitals, Bangalore, India.
The Journal of Vascular Access
|February 28, 2022
Summary
The BD Venflon™ I with Instaflash needle technology significantly improved first attempt peripheral intravenous catheter insertion success rates. This innovation enhances patient and nursing satisfaction, offering a superior alternative for clinical settings.
Area of Science:
- Medical Devices
- Clinical Nursing
- Vascular Access
Background:
- Peripheral intravenous catheters (PIVCs) are essential for patient care but multiple insertion attempts cause discomfort and increase costs.
- Reducing PIVC insertion attempts improves patient and nursing satisfaction and lowers healthcare expenditures.
- The study compares a novel PIVC with Instaflash needle technology against a standard device.
Purpose of the Study:
- To evaluate the performance efficacy of BD Venflon™ I with Instaflash needle technology.
- To compare the first stick success rate, ease of insertion, and patient satisfaction between the investigational and control devices.
- To determine if the new technology offers an improved alternative for PIVC insertion.
Main Methods:
- A randomized controlled trial comparing BD Venflon™ I with Instaflash needle technology (investigational) to BD Venflon™ without Instaflash (control) in a 1:1 ratio.
- Monitoring first stick success rate, ease of insertion, and patient satisfaction.
- Statistical analysis using R 4.0.3, Microsoft Excel, and Chi square tests.
Main Results:
- The investigational device achieved a 98.72% first attempt success rate versus 88.87% for the control device (p=0.0004).
- Ease of insertion was high for both devices (98.71% investigational vs. 99% control), indicating nursing personnel satisfaction.
- Patient satisfaction was also high for both, with 98.01% for the investigational and 99% for the control device.
Conclusions:
- BD Venflon™ I with Instaflash needle technology significantly enhances first attempt insertion success.
- The new technology demonstrates comparable ease of insertion and high patient satisfaction levels.
- This device represents a valuable advancement, improving patient outcomes and clinical efficiency in hospitals.

